Cargando…

Chart validation of an algorithm for identifying hereditary progressive muscular dystrophy in healthcare claims

BACKGROUND: Muscular dystrophies (MDs) are a group of inherited conditions characterized by progressive muscle degeneration and weakness. The rarity and heterogeneity of the population with MD have hindered therapeutic developments as well as epidemiological and health outcomes research. The objecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiaoxue, Agiro, Abiy, Martin, Ann S., Lucas, Ann M., Haynes, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688201/ https://www.ncbi.nlm.nih.gov/pubmed/31399066 http://dx.doi.org/10.1186/s12874-019-0816-7

Ejemplares similares

Advance Care Planning Claims and Health Care Utilization Among Seriously Ill Patients Near the End of Life
por: Ashana, Deepshikha Charan, et al.
Publicado: (2019)

Antibiotic dispensing following pediatric visits in the US emergency departments and outpatient settings from 2006 to 2016
por: Agiro, Abiy, et al.
Publicado: (2019)

Validation of a claims-based algorithm identifying eligible study subjects in the ADAPTABLE pragmatic clinical trial
por: Fishman, Ezra, et al.
Publicado: (2018)

Validation of an algorithm for identifying MS cases in administrative health claims datasets
por: Culpepper, William J., et al.
Publicado: (2019)

Validity of Physician Billing Claims to Identify Deceased Organ Donors in Large Healthcare Databases
por: Li, Alvin Ho-ting, et al.
Publicado: (2013)

Validation of claims data algorithms to identify nonmelanoma skin cancer
por: Eide, Melody J., et al.
Publicado: (2012)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis
por: Wang, Junjie, et al.
Publicado: (2021)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
por: Ogundele, Michael, et al.
Publicado: (2021)

Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data
por: Thurin, Nicolas H., et al.
Publicado: (2021)

Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry
por: Cowen, Leslie, et al.
Publicado: (2019)

Development of a Claims-Based Algorithm to Identify Patients With Agitation in Alzheimer’s Dementia
por: Hwang, Steve, et al.
Publicado: (2020)

Birdshot chorioretinopathy in a male patient with facioscapulohumeral muscular dystrophy
por: Papavasileiou, Evangelia, et al.
Publicado: (2015)

The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw
por: Wright, Nicole C., et al.
Publicado: (2015)

Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims Data
por: Esposito, D. B., et al.
Publicado: (2019)

Validation of a claims‐based algorithm to identify cases of ulcerative colitis in Japan
por: Ogino, Haruei, et al.
Publicado: (2021)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Cardiomyopathy in Duchenne Muscular Dystrophy: A Single-Center Experience
por: Kummitha, Karthikeyan, et al.
Publicado: (2022)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Development and Validation of an Algorithm to Identify Patients with Multiple Myeloma Using Administrative Claims Data
por: Princic, Nicole, et al.
Publicado: (2016)

Development and Validation of Coding Algorithms to Identify Patients with Incident Non-Small Cell Lung Cancer in United States Healthcare Claims Data
por: Beyrer, Julie, et al.
Publicado: (2023)

Emery–Dreifuss muscular dystrophy: a test case for precision medicine
por: Pillers, De-Ann M, et al.
Publicado: (2016)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
por: Kang, Peter B., et al.
Publicado: (2023)

Development and Validation of an Outpatient Clinical Predictive Score for the Diagnosis of Duchenne Muscular Dystrophy/Becker Muscular Dystrophy in Children Aged 2–18 Years
por: Sharawat, Indar Kumar, et al.
Publicado: (2023)

Cancer risk among patients with hereditary muscular dystrophies: a population-based study in Taiwan, 1997-2009
por: Lin, Gen-Min, et al.
Publicado: (2014)

Fatty liver disease and hypertransaminasemia hiding the association of clinically silent Duchenne muscular dystrophy and hereditary fructose intolerance
por: Paolella, Giulia, et al.
Publicado: (2012)

Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead
por: Heslop, Emma, et al.
Publicado: (2021)

Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies
por: Ganassi, Massimo, et al.
Publicado: (2022)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Validation of Persian Individualized Neuromuscular Quality of Life in patients with muscular dystrophies
por: Moradi, Kamyar, et al.
Publicado: (2020)

Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies
por: James, Meredith K, et al.
Publicado: (2022)

Validation of Algorithms to Identify Bone Metastases Using Administrative Claims Data in a Japanese Hospital
por: Hirano, Takahiro, et al.
Publicado: (2023)

Studies of pseudohypertrophic muscular dystrophy
por: Bonsett, Charles A., 1921-
Publicado: (1969)

Autonomic regulation in muscular dystrophy
por: Angelini, Corrado, et al.
Publicado: (2013)

Autonomic regulation in muscular dystrophy
por: Sabharwal, Rasna
Publicado: (2014)

Improving the course of muscular dystrophy?
por: NIGRO, VINCENZO
Publicado: (2012)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gmf6bt3o6v92207hdidkm6vtcn